Antitrust Group

ID: 1b83db51-2619-30fb-68c4

/

Unclaimed

/

Organization: Goodwin Procter

Antitrust & Competition Life Sciences Year in Review 2023

Life Sciences Perspectives · February 22, 2024

United States: Trends of Agency Scrutiny on Pharmaceutical Transactions Expected to Shift Amid Rise in Deal Activity (GCR)

Life Sciences Perspectives · November 6, 2023

Antitrust & Competition Life Sciences Quarterly Update Q3 2023

Life Sciences Perspectives · October 26, 2023

Bloomberg Intelligence – Arman Oruc’s Perspective on the FTC and Pharma and Biotech Industry M&A Impact

Life Sciences Perspectives · September 28, 2023

Antitrust & Competition Life Sciences Quarterly Update Q2 2023

Life Sciences Perspectives · August 11, 2023